Lauren Santye, Assistant Editor

Top news of the day from across the health care landscape.

Mice treated prophylactically were protected from developing multiple sclerosis and neurological deficits.

Top news of the day from across the health care landscape.

BAX 930 mimics a key clotting enzyme, and could one day eliminate the need for plasma infusions for hereditary thrombotic thrombocytopenic purpura.

Same-day results increase the number of individuals who get tested and treated for HCV.

Novel technique provides clues to differentiate progressors from non-progressors in AMD.

Top news of the day from across the health care landscape.

Draft guidance seeks to enhance equivalence testing for biosimilars.

The 15-page document offers guidance on statistical approaches to evaluating biosimilar similarity.

Top news of the day from across the health care landscape.

Results of the case could alter the future of the biosimilar marketplace.

Introducing microbes to replace missing metabolites could reduce cancer risk, study suggests.

Top news of the day from across the health care landscape.

The Distinguished Service Award is given annually to an individual who has made a sustained contribution to leadership within NASP and the specialty pharmacy industry.

Current policy reduces incentives that would spur a robust biosimilars market, according to the Biosimilars Council.

Top news of the day from across the health care landscape.

Findings further strengthen the need to protect young people from head injury.

Physical activity and a whole grain-rich diet lowers colorectal cancer risk, whereas red meat increases the risk.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, explains how mobile health can affect specialty pharmacies.

Findings may lead to future treatments for patients with psoriasis and psoriatic arthritis.

Variation in HPV15 E7 protein greatly decreases the risk of invasive cervical cancer.

Top news of the day from across the health care landscape.

Study findings could lead to new treatment options for patients with IBD in the future.

Findings may provide new treatment options for Duchenne muscular dystrophy.

Biosimilars offer the potential to provide patients with less costly alternatives.

Wnt signaling activation impacts the response to melanoma treatment.

Patients with stage 3 kidney disease cured of hepatitis C virus experienced an improvement in kidney function following treatment.

Company harnesses CRISPR-based gene editing technology as it enters human clinical trials to treat HIV.

Top news of the day from across the health care landscape.

New biosimilars could play an important role in helping spur competition that can lower health care costs and increase access to important therapies.